Trial Profile
A Study to Evaluate the Prevalence of Metabolic Syndrome in Patients With Schizophrenia Treated With Paliperidone Palmitate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Apr 2016
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- 07 Apr 2016 New trial record
- 01 Apr 2016 Results published in the Journal of Clinical Psychopharmacology